R&D Systems Inc. Tocris Bioscience Boston Biochem

Gabapentin

Cat. No. 0806

Gabapentin C9H17NO2 [60142-96-3]

Price and Availability

For Gabapentin pricing & availability please select your country from the drop down menu:
Submit
By clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy.

Chemical Name: 1-(Aminomethyl)cyclohexaneacetic acid

Biological Activity

Anticonvulsant with several possible mechanisms of action. Increases GABA in the brain and binds to a novel site associated with voltage-sensitive Ca2+ channels. Prevents neuronal death and is antinociceptive and anxiolytic.

Licensing Information

Sold for research purposes under agreement from Pfizer Inc.

Technical Data

M.Wt:
171.24
Formula:
C9H17NO2
Solubility:
Soluble to 100 mM in water with gentle warming
Purity:
>99 %
Storage:
Desiccate at +4°C
CAS No:
60142-96-3

The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.

Certificate of Analysis / Safety Data Sheet

Certificate of Analysis: View current batch
Select another batch:
Safety Data Sheet: View Safety Data Sheet

References

Upton (1994) Mechanisms of action of new antiepileptic drugs: rational design and serendipitous findings. TiPS 15 456. PMID: 7886818.

Taylor et al (1998) A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res. 29 233. PMID: 9551785.

Fink et al (2000) Inhibition of Ca2+ influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices. Br.J.Pharmacol. 130 900. PMID: 10864898.

Timmerman et al (2000) A microdialysis study on the mechanism of action of gabapentin. Eur.J.Pharmacol. 398 53. PMID: 10856447.

If you know of a relevant citation for this product please let us know.

Keywords: Gabapentin, supplier, Anticonvulsant, Increases, brain, GABA, Binds, voltage-sensitive, Ca2+, channels, GABAB, Receptors, GABAA, GABAC, Calcium, CaV, Channels, L-Type, P-Type, R-Type, Q-Type, T-Type, N-Type, voltage-gated, voltage-dependent, Pfizer

Quick Order

Find multiple products by catalog number

divider line

Pain Research Guide

Reserve your free copy

Pain Research Guide

Highlights over 280 products for Pain research. Reserve copy

divider line

GABA Review

GABA Receptors Review

Written by Ian Martin, Norman Bowery & Susan Dunn. Request a copy or view PDF today.

divider line

7-TM Receptor Signaling

Written by T. Kenakin et al

7-TM Poster

'Seven Transmembrane Receptor Signaling' highlights the multiple behaviors of 7-TMs including G-protein-dependent and -independent signaling as well as the concept of collateral efficacy

divider line

Therapeutic Strategies in Schizophrenia

Written by J. Lieberman

Schizophrenia Poster

'Schizophrenia - Emerging Targets and Therapeutic Strategies' provides a summary of the targets and pathways representing the most promising strategies to pursue for novel drug development.

divider line

New Product Guide

NPG

Highlights over 130 new products added in 2012. Request a copy or view PDF today.

divider line

New Products in this Area

CYM 50308

Potent and selective S1P4 agonist

H2L5186303

Potent and selective LPA2 receptor antagonist

MEDICA 16

FFA1 (GPR40) agonist. Also inhibits ATP citrate lyase

BX 471

Potent, selective CCR1 antagonist

PF 04418948

Potent and selective EP2 receptor antagonist

Latanoprost

FP prostaglandin receptor agonist; also exhibits agonist activity at EP1 and EP3 receptors

GRI 977143

Selective LPA2 receptor non-lipid agonist

CYM 50260

Potent and selective S1P4 agonist

G-36

Selective GPR30 antagonist

Strontium chloride

Calcium sensing receptor (CaSR) agonist

CS 2100

Selective S1P1 agonist

SMANT hydrochloride

Inhibits Smoothened (Smo) accumulation

TUG 891

Potent and selective GPR120 agonist

IT1t dihydrochloride

Potent CXCR4 antagonist

RuBi GABA trimethylphosphine

Caged GABA; inhibits neural activity

Sign-up for new product e-alerts
divider line

20% Discount*

Potent, selective LRRK2 inhibitor

Potent LRRK2 inhibitor now available from Tocris Bioscience

Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.

* Terms & conditions